Praveen Advani, Janssen Pharmaceuticals
Praveen Advani, Commercial Insights & Strategy Lead – US Diabetes, Janssen Pharmaceuticals
Praveen Advani has more than 18 years of experience leading US & Global market research efforts for in-line brands & new products in the Pharmaceutical Industry. Praveen is currently the Commercial Insights & Strategy Lead – US Diabetes at Janssen Pharmaceuticals. In this role, Praveen is responsible to lead the commercial excellence efforts (market research, forecasting, advanced analytics and competitive intelligence) for Invokana in the US.
Praveen has been instrumental in successfully leading global market research teams for several major global launches, most recently as the Executive Director for WW Immuno-Oncology at Bristol-Myers Squibb where he was responsible for leading all the US and International market research efforts to help successfully launch one of the fastest growing brands in the industry – Opdivo. Prior to that, he has successfully led the market research efforts for Januvia/Janumet (Diabetes, Merck) and Lantus (Diabetes, Aventis/Sanofi)
Praveen holds a MBA from Thunderbird, The American Graduate School of International Management and a Bachelors degree in Engineering from the University of Pune, India.
Wasse Alemayehu, Shire Pharmaceuticals
Wasse Alemayehu, Director of Global Marketing Research, Shire Pharmaceuticals
Wasse Alemayehu is a veteran of marketing research, analytics and forecasting working for some of the major pharmaceutical companies and research suppliers.
Wasse has served as a senior statistician for Walsh America (currently part of Walter Kluwer) where he developed the first physician-level data as part of a team. In that capacity he has consulted with some of the major Pharma companies for data analytics and how to leverage data to make business decisions.
Wasse was also the Global Director of Business Analysis for Pharmacia where he was responsible for integrating the global efforts and building world-class research group. After Pharmacia was acquired by Pfizer Wasse moved to iNcord Communications (a creative agency) where he served as the VP of marketing research, analytics, and competitive Intelligence.
Wasse has a bachelor’s degree in Mathematical Economics, Masters in Econometrics, and an MBA in statistical analysis.
Sylvester Allen, Teva Pharmaceutical
Sylvester Allen, Brand Marketing Research Analyst, Teva Pharmaceutical
Renata Alves, Pfizer
Renata Alves, Sr. Manager, Business Analytics and Insights, Xeljanz HCP Lead, Pfizer
• Business Analytics Lead for Rare Diseases US with Pfizer
• 15 years in the Pharma Industry
Previous Roles Include:
• Specialty Care Business Analytics
• Business development for Astra Zeneca Mexico
• Strategic consultancy for start-up pharmaceutical company in Portugal
• 4 years of Regulatory Affairs experience working for the biologics division of Aventis
• MBA from MIT SLOAN School of Business majoring in Health Care and Marketing with a minor in International Business
• BA in Publicity and Advertising from Universidade Federal Fluminense, Brazil
• BA in Journalism from Universidade Federal Fluminense
Lauren Altman, Lieberman
Lauren Altman, Senior Vice President, Lieberman
Lauren has extensive experience in the healthcare sector. She began her career in pharmaceutical advertising, working on the launch of new medications in several therapeutics areas. She currently combines this experience with her educational background in research methods to service many of our healthcare clients.
Lauren has been with Lieberman for over 7 years, and currently manages some of the company’s largest global studies. Her expertise spans most therapeutic categories. She holds a BS in Biometry and Statistics from Cornell University.
Jonathan Asher, PRS IN VIVO
Jonathan Asher, Executive Vice President, PRS IN VIVO
As Executive Vice President at PRS IN VIVO, the world’s leading shopper and packaging research firm, Jonathan manages several client relationships, supervises the Account Executive group and oversees the firm’s marketing efforts.
Asher has over thirty years’ experience in both marketing research and brand design for consumer packaged goods.
A frequent speaker and lecturer on topics pertaining to marketing and design, Jonathan has been quoted in major publications, including Fortune, The New York Times, The Wall Street Journal, Brandweek, Advertising Age and Brand Packaging. Jonathan has appeared on “ABC World News Tonight,” the “CBS Evening News,” “CNN Headline News,” “Fox Network News,” NBC’s “Today” show, ABC Radio and CNBC’s “On The Money.” He is also a faculty member of the Path To Purchase Institute.
Naiyer Azam, Kyowa Kirin International plc.
Naiyer Azam, Director, New Product Planning, Kyowa Kirin International plc.
Arvind Balasundaram, Sanofi
Arvind Balasundaram, Head, Global Customer Insights, Sanofi
Arvind leads the Global Customer Insights function at Sanofi, where he oversees the implementation of innovative capabilities to enhance the understanding of customer choices and preferences. Prior to Sanofi, Arvind also spent time at Johnson & Johnson, BMS & Pfizer, mostly on the early pipeline and launch side of the business. During his tenure at these companies, he participated in a number of industry-leading pharma brand launches, spanning several therapeutic areas.
Arvind completed his MBA from the Owen Graduate School of Management at Vanderbilt University, and recently earned the Award of Achievement in Digital Analytics from the University of British Columbia (in association with the Digital Analytics Association). He is currently pursuing a certification in Data Science at UC, Irvine (in association with Predictive Analytics World).
Arvind is a past President of the Pharmaceutical Management Science Association (PMSA). His interests include exploring new capabilities to enrich understanding of customer experience in multichannel business ecosystems, as well as identifying choice contexts and decision biases in noisy decision-making environments.
Steve Bell, AplusA Bell Falla
Steve Bell, Senior Partner, AplusA Bell Falla
Steve Bell is a statistician and consultant specializing in pharmaceutical markets and quantitative marketing research methods. Steve has applied his statistical and software development background to create several original quantitative methods tailored to the needs of pharmaceutical marketers. From 1989—1998, Steve was an Assistant Professor of Marketing at the Stern School of Business, New York University. From 2002—2016, together with Juan Falla, Steve was a Founder and Senior Partner of Bell Falla. Since June 2016, Steve has been Senior Partner of AplusA Bell Falla. Steve has a B.A. from Davidson College, M.S. from Texas A&M University, and an MBA and Ph.D. from Columbia University.
Kim Bowers, Brädo Creative Insight
Kim Bowers, Vice President, Group Leader, Brädo Creative Insight
A former advertising agency Account Planner, Kim Bowers has ample understanding of the advertising creative process, and a healthy respect for both the limits and potential of market research. Kim has seen first-hand the value of creating successful communications, and she uses this knowledge and experience to add creative depth to the insight developed by the Brädo team.
Kim started her career at Brädo in Creative Strategy, executing a number of strategic projects related to brand positioning, messaging development, creative execution and new product development for Brädo’s global clients. She now is Brädo’s Senior Director of Business Unit Consulting, acting as an internal consultant regarding development of new business units in order to ensure that Brädo continues to meet the changing market research needs of their clients. Kim has significant experience in the pharmaceutical category, specifically in the area of women’s health, and has played key role in a number of major global brand launches over the years.
Kim Bowers has a Master’s Degree in Strategic Communications from the University of Missouri – School of Journalism.
Terri Boyd, J&J
Terri Boyd, Procurement, Market Research, J&J
Prior to joining Procurement, Terri held several roles within Business Analytics/Market Research for 19 years. Her Market Research experience spans both medical devices and pharmaceuticals. During her 19 year tenure at J&J, Terri spent 4 years at Cordis providing both Market Research and initiating a Competitive Intelligence department, another 4 years at Ortho Biotech conducting both primary and secondary research and 7 years at Tibotec Therapeutics managing Market Research, Competitive Intelligence and Sales Operations.
Prior to joining Johnson & Johnson, Terri was employed by Hoechst Roussel Pharmaceuticals (now Sanofi Aventis) where she was the Director of Market Research/Analytics. Before moving into the Pharmaceutical side of the world, Terri was an Account Representative for IMS Health. Terri’s current role in Procurement blends her knowledge of Market Research and her relationships with the suppliers to bring value to her business partners.
Amanda Buonopane, Segmedica
Amanda Buonopane, Research Director, Segmedica
Amanda Buonopane, MA, is a Ph.D. candidate in Cultural Anthropology. She specializes in ethnographic research and has over 10 years of experience conducting international as well as domestic qualitative research. Prior to working for Segmedica Amanda worked as an adjunct professor at several universities in Western New York, teaching social science topics, including qualitative research methods. As lead researcher, she applies her ethnographic and qualitative interviewing expertise to gain insightful feedback that gets to the root of specified business objectives.
Laura Radosh Butt, LBR Insight
Laura Radosh Butt, Managing Director, LBR Insight
Laura Radosh Butt formed LBR Insight in 2006 after years of leading strategic planning efforts at top advertising agencies, such as McCann, J. Walter Thompson and Deutsch. At these agencies, not only was Laura accountable for turning research insights into action and moderating qualitative research on a variety of topics, but she also helped to build their current healthcare marketing departments that many of you may work with everyday. Laura has moderated hundreds upon hundreds of healthcare discussions with both patients and HCPs for many top-rated Pharmaceutical companies. She is a graduate of the University of Pennsylvania and is a RIVA trained moderator.
Lillian Cao, Taiho Oncology Inc.
Lillian Cao, Director, New Product Planning, Taiho Oncology, Inc.
Lillian Cao is a marketing, strategic planning, and commercial effectiveness leader recognized for excellent collaboration, communication, and business analysis skills, with a track record of accelerating business growth in complex and challenging environments. In her current role as a Director of New Product Planning, she provides commercial insights and enables sound strategic decisions for pipeline assets and US licensing opportunities.
Lillian has more than 14 years of experiences working with primary care, specialty, and orphan drug products. Her experiences in forecasting, market research, sales effectiveness, in-line brand marketing, and new product commercialization shaped her perspective on market researches. Before moving to pharmaceutical companies, she was also a management consultant with The Boston Consulting Group (BCG), developing sales and marketing strategies for pharmaceuticals, consumer goods, high tech, and financial services companies.
Lillian holds an MBA from The Stanford Graduate School of Business and a B.A. from Fudan University.
Laura Carter-Scheid, Phoenix Marketing International
Laura Carter-Scheid, Vice President, Phoenix Marketing International
Millie Cason, Biogen Idec
Millie Cason, Director, Global MS Customer & Markets Insights, Biogen Idec
Seth Cohen, Novartis
Seth Cohen, Market Research Lead Entresto, Novartis
Lisa Courtade, Merck
Lisa Courtade, Executive Director, Global Customer & Brand Insights, Merck
A strategic, solutions oriented business leader with over 20 years of success in delivering customer insights that drive business results, Lisa has a passion for the healthcare industry and for the patients we serve. Lisa Courtade currently leads executional excellence and the transformation of insights generation at Merck as the Executive Director of Global Market Research Excellence. In this role, she and her team are responsible for driving business results and creating customer value by delivering value based innovation. Lisa was an early adopter of engaging patients in marketing research and leveraging CPG methodologies in the pharma space which contributed to receipt of the ARF’s David Ogilvy Award for creative use of insights in celebrate breakthrough moments when creative inspiration and research insights come together to produce a spectacular advertising campaign.
Lisa lives her passion for shaping the future of the industry by serving on the Marketing Research Institute International Board (MRII) as Chair of the Pharma Curriculum Committee and as an Advisory Board & Steering Committee member for the University of Georgia’s Masters in Marketing Research program, where she also serves as an alumni mentor. Lisa is an active member of the Healthcare Businesswoman’s Association (HBA) where she chaired Career Development and served as the first Global Research Director. In 2013 Lisa was awarded the PMRG’s prestigious R.R. Fordyce Award for exemplary leadership, service and dedication to the healthcare industry and the healthcare market research community.
Renu Dalal, Phoenix Marketing International
Renu Dalal, Vice President, Client Services, Phoenix Marketing International
Amalia De Luca, Lifescience Dynamics
Amalia De Luca, Ph.D., Consultant, Lifescience Dynamics
Amalia is based in the London office as a consultant. She is involved in market research, competitive intelligence and market access consulting projects across various therapeutic areas including oncology, rheumatology and inflammatory diseases. She is also experienced in medical devices and diagnostics. As a consultant at Lifescience Dynamics, she works as a part of a team committed to helping develop executable strategies for clients around the globe and she is a full member of the client engagement team.
Amalia, whose native language is Italian, is also fluent in English. She works closely with the Italian market.
She holds a PhD in Bioengineering applied to cardiovascular sciences from Imperial College London, where she took part in a multidisciplinary project investigating the causes of atherosclerosis. She also holds a BSc and MSc in Medical Engineering from the University of Rome.
Outside of work, Amalia enjoys travelling and discovering new cultures. She is also a food lover and cannot turn down a glass of good Italian wine.
Tim Deckman, RG+A
Tim Deckman, Vice President and Chief Marketing Scientist, RG+A
Dr. Deckman is responsible for executing all phases of RG+A’s advanced and proprietary methodologies, serving as a methodological expert for clients as well as internal teams. Tim works to ensure that RG+A maximizes the accuracy and amount of actionable insights provided to clients from the data collected.
Tim worked at RG+A from 2012 to 2014 as a research analyst and research manager. In these positions he assisted with proposal development, wrote survey instruments, conducted analyses, and wrote final reports. Tim rejoined the RG+A team in June of 2015 as Associate Methodologist and has since secured the role of Vice President and Chief Marketing Scientist. In his new role, Tim is able to continue to leverage his background in experimental design and advanced statistics to help design projects, execute advanced analytics, train junior staff, and convey complex analyses and results to non-technical audiences.
Tim has experience executing quantitative and qualitative studies both domestically and internationally. Tim has gained valuable experience conducting market research projects across multiple therapeutic areas, including: oncology, blood disorders, psychological disorders, cardiovascular disorders, as well as orphan conditions.
Tim holds a B.S. in Psychology from St. Lawrence University and a M.S. and Ph.D. in Experimental Psychology from the University of Kentucky.
Michael Devinoff, Bristol-Myers Squibb
Michael Devinoff, Vice President – Head of Forecasting, Bristol-Myers Squibb
Michael has been with Bristol-Myers Squibb Co. for over 10 years. During his tenure at BMS, Michael has perfected his Marketing Research skills through ever-expanding roles within both the core US Pharmaceuticals and Global Marketing/Commercialization organizations. He has led teams of Marketing Research analysts across various products and therapeutic categories. His extensive efforts within the Cardiovascular group has helped grow the company’s most significant product, Plavix, into the world’s 2nd largest pharmaceutical brand.
Prior to his time with BMS, Michael spent four years with NFO-Migliara/Kaplan Associates, an industry-leading Marketing Research consulting company. There he successfully built a multi-million dollar base of client business and led a broad team of research analysts addressing strategic business questions across products spanning a variety of therapeutic categories and life-cycle stages.
Prior to his nearly 15 year tenure within the marketing research industry, Michael honed his analytical and business skill set through experiences working at Becton Dickenson & Co. (marketing/marketing research), Baskin-Robbins (store management), Curtis 1000 (sales), and Red Robin Restaurants (store management & training).
Michael holds an MBA in Marketing from Rutgers University Graduate School of Management, and a BS in Biology/Genetic Engineering from Binghamton University.
Michael and his family live in the Princeton, NJ area.
Laurel DiBrog, Roswell Park Cancer Institute
Laurel DiBrog, Chief Marketing Officer, Roswell Park Cancer Institute
Judy Droar, Ipsen
Judy Droar, Director, Ipsen
Sandipa Dublish, Celgene
Sandipa Dublish, Senior Director Market Research Inflammation & Immunology, Celgene
Sandipa Dublish is a Decision Sciences leader in biopharmaceuticals. Prior to her position at Celgene, she was Executive Director Commercial Insights & Analytics at Alexion, a biotech specializing in rare diseases, where she built a strong Global function. Her career history includes companies such as Novartis, Bristol-Myers Squibb, and Eisai. Sandipa holds a Ph.D. in Marketing from Florida International University, Miami.
Analia de la Fuente, UCB
Analia de la Fuente, Vice President & Global Head of Patient & Ecosystem Insights Practice, UCB
Joaquin Garcia-Lopez, Janssen
Joaquin Garcia-Lopez, Associate Director, Global Market Research, Janssen
Joaquin is the global market research lead for Alzheimer’s Disease within Janssen’s Global Commercial Strategy Organization. Joaquin’s overarching objective is to maximize the long-term value of Janssen’s global assets and portfolio by shaping strategic business decisions based on actionable insights and recommendations generated through predictive, innovative and integrated analytics.
Prior to joining Janssen, Joaquin served as Vice President in the healthcare team at ORC International, a market research and business intelligence firm. In this role, Joaquin worked with a broad portfolio of clients, including ten of the top 12 global pharmaceutical companies. He led consultative market analytics that met a broad range of business needs, including new product development and indication assessments, patient and HCP insight analysis, lifecycle management strategies, therapy area tracking, competitive landscapes and diverse types of innovative market analyses.
Joaquin started his pharmaceutical career 16 years ago, as a bench engineer at Forticell Bioscience’s process development group, where he had a leading role in a broad range of projects relating to the development and launch of novel cell therapies and advanced biomaterials.
Joaquin graduated from Columbia University with both an MS in Technology Management/Biopharma and a BS in Biomedical Engineering and holds a B.A. in Mathematics from Fordham University.
Ed Geiselhart, Cello Health Insight
Ed Geiselhart, Director, Cello Health Insight
Ed Geiselhart is an accomplished advocate for user-centered design and the power of design thinking to make a meaningful difference in helping clients bring innovation to the market. He has nearly 25 years of consulting experience in the healthcare and pharmaceutical industries, with a focus on connecting user insights with business decisions, marketing strategy, innovation planning, and device design.
Andrea Geppert, Strongbridge Biopharma
Andrea Geppert, Sr. Product Manager, Strongbridge Biopharma
Andrea Geppert is the Senior Product Manager of the Marketing team at Strongbridge Biopharma PLC. After recent research was conducted in Primary Periodic Paralysis (PPP), Andrea took the results and helped drive the creation of the brand’s patient materials for launch, which is most relevant. Prior to Strongbridge Biopharma, Andrea worked in Marketing at CSL Behring. Andrea graduated from Saint Joseph’s University with a degree in pharmaceutical marketing and is currently enrolled at DeSales University for her MBA in Healthcare Systems Management.
Ellen Gordon, RG+A
Ellen Gordon, Senior Vice President and Head of Research, RG+A
Dr. Gordon joined RG+A in 2017 as Senior Vice President and Head of Research. In this role, Ellen leads client service and works collaboratively with the research team to execute innovative insights and develop strategic programs across all of RG+A’s client engagements.
Ellen has over 20 years of experience in healthcare and pharmaceutical research. She brings an extensive background in designing and executing strategic research solutions that leverage custom and syndicated pharmaceutical research, utilizing both qualitative and quantitative methodologies in the US and globally. Additionally, she has conducted market research in multiple therapeutic areas, including diabetes, oncology, cardiovascular disease, and rare diseases.
Prior to joining RG+A, Ellen held senior positions at Fulcrum Research Group, ImpactRx and Market Strategies International where her responsibilities included developing and growing global pharmaceutical client practices, introducing iPad-enabled research panels in multiple countries, leading teams responsible for the execution and delivery of both custom and syndicated global market research, generating new business, and moderating physician and patient interviews.
Ellen holds a B.A. in Politics from Brandeis University, an MA in Russian Studies from Georgetown University and a Ph.D. in Political Science from the University of Michigan.
Rebecca Gould, Fulcrum Research Group
Rebecca Gould, Executive Vice President, Fulcrum Research Group
Rebecca has over 10 years of experience in custom market research focused exclusively on the biopharmaceutical / medical device industries. Rebecca enjoys both qualitative moderating and quantitative analysis and excels at leading projects that deliver usable insights. While Rebecca’s clients span a range of therapeutic areas, she has extensive experience working with rare diseases and understanding their unique challenges. Rebecca holds a BA in psychology from Wesleyan University.
Stuart Greenberg, Bayer
Stuart Greenberg, Deputy Director, Global/Oncology Market Research, Bayer
Dr. Stuart E. Greenberg is currently Deputy Director, Global / Oncology Market Research at Bayer. His responsibilities include qualitative and quantitative primary research, secondary research, forecasting and market size and structure analysis. In the past he has been on the Global Market Research teams of Pfizer, Pharmacia, Searle, Roche Diagnostics and Boehringer Mannheim. Stuart has managed market research on cancer treatment and prevention drugs, blood glucose monitors, point of care testing equipment and ophthalmic instruments. Stuart earned his undergraduate degree from Lafayette College and achieved a Masters and PhD in Industrial/Organizational Psychology at Virginia Tech.
Roger Green, RG+A
Roger Green, President/CEO, RG+A
Mr. Green founded RG+A in 1991 and serves as President and Chief Executive Officer. Over the past twenty years, Roger has worked to design marketing research methods, insights, and modeling tools that promote greater understanding of what drives value in pharmaceutical markets. He is the primary developer of Dynamic Practice Simulation® (DPS®), RG+A’s proprietary patient-simulating marketing research system, which has been applied successfully in virtually every major market around the world.
Mr. Green has sat on editorial boards, has written articles and participated in roundtables for leading industry publications, and lectured widely at prominent university programs involved with marketing research and pharmaceutical marketing. He received a BA in political science and an MBA in marketing from Columbia University.
Mr. Green is the 2008 recipient of the R.R. Fordyce Award, an honor bestowed upon leaders in the marketing research industry dedicated to the betterment of the profession.
Anne Hale, Pfizer
Anne Hale, Business Analytics and Insights NA Lead, Pfizer
Dr. Hale has been with Pfizer’s market analytics group for 10 years. In addition to this role, she also leads the Center of Excellence for HCPs, which is tasked with identifying innovative, efficient research solutions for business issues and decisions relating to our physician customers. She has held several other positions within Pfizer, including the Market Analytics Team Leader for Urology/Respiratory brands, as well as Global Market Analytics Team Leader for New Product Development for a wide range of therapeutic areas.
Prior to joining Pfizer, Anne was a Marketing Professor at both McGill University in Montreal and the University of Victoria in Victoria, British Columbia, Canada, where she taught such courses as Marketing Management, Marketing Research, Business Statistics, Advertising, and Retail Management at both the undergraduate and graduate levels. In addition, she also served a term as Dean of the Undergraduate Program at both McGill University and the University of Victoria, as well as teaching in the Executive Education Institutes of both universities.
Anne holds a Bachelor of Business Administration, Masters of Business Administration and a Doctorate in Marketing, specializing in quantitative methodology, all from the University of Texas at Austin.
James Heasley, Evolution Consulting & Research
James E. Heasley II, Ph.D. Principal, Evolution
Dr. Heasley has developed extensive expertise in the areas of marketing and marketing research with over 19 years of consulting in the pharmaceutical industry. He has consulted with nearly all of the major biopharmaceutical firms in most key therapeutic categories. In recent years, he has worked extensively with brands in oncology, immunology and infectious disease. Most recently, Dr. Heasley has worked on a range of pre-launch activities (Phase III trial design, pre-positioning, branded and unbranded messaging, etc.) for biotech agents, as well as conducting post-launch market assessments for major brands.
Over the past two decades, Dr. Heasley has spent time teaching at various universities and has been published many times. One of his key goals is to continuously evolve and develop innovations that will aid modern marketers and marketing researchers in the process of adding value as the biopharmaceutical industry continues to evolve. Two of his most recent developments include Platform Positioning and Messaging, Minimal Expectations Modeling (MEMSM) and the qualitative conjoint method PreSIMSM. Dr. Heasley currently serves as the Chair of the Temple University Political Science Advisory Board.
Michael Henrick, Medac Pharma
Michael Henrick, Director Commercial Operations, Medac Pharma
Michael Henrick is the Director of Commercial Operations where he manages the non-financial analytics in both business development and existing products and leads the sales operations functions for Medac’s specialty sales force. Mike has 10 years of experience in small and medium pharma. Prior to Medac, Mike had a series of roles with increased responsibility with Astellas Pharma working across their Hospital, Transplant, and Oncology sales teams developing system-wide view of corporatized customers to show system impacts, key accounts, and prescribers, and the total system value across all products and franchises. Led the development of tools including integration and interpretation of affiliation data.
Dani Heywood, Branding Science
Dani Heywood, President, Branding Science
Dani is originally from the UK, but has been based in the US since 2004, and currently leads the Branding Science US offices. She holds a PhD from Leeds University, UK focused on looking at molecular genetics of vascular disorders. Prior to going agency side, she worked with Unilever in the hair care division for 5 years, where she developed a passion for understanding brands and consumers. Since then she has been focused in growing teams and companies exclusively in global healthcare market research. Oncology, rare diseases and animal health are her main areas of therapy area expertise, and she has experience across the gamut of both qualitative and quantitative methodologies, especially those requiring a high level of creativity.
Venky Jagannathan, Strategic Research Insights (SRI)
Venky Jagannathan, Principal, Strategic Research Insights (SRI)
Venky has two decades of experience in the consulting industry, primarily focused on the pharmaceutical industry. He has pioneered the use of Big Data for pharmaceutical clients and has guided new product launch teams with appropriate use of different data sources. He is a noted expert on brand equity tracking, detail quality monitoring, and demand estimation. He has presented papers at industry conferences on achieving excellence in message recall studies and trained clients on quantitative marketing research. Venky has tremendous experience in handling corporate-wide brand equity and message recall engagements. He has guided several pharmaceutical firms on standardization of tracking approaches and improvement of quality across markets. His experience spans many therapy areas including anti-psychotics, allergy, asthma, CNS, nephrology, hypertension, ophthalmology, immunology, infectious diseases, oncology, and Hepatitis C. Areas of specializations include sales force productivity, detail quality monitoring, attitude tracking, segmentation, and product optimization. His work on applying Six Sigma principles for Marketing is patented by GE. He holds an MBA and a Ph.D. in Marketing.
Ken Kirsch, Jazz Pharmaceuticals
Ken Kirsch, Senior Manager, Market Intelligence, Jazz Pharmaceuticals
Ken Kirsch is a Pharmaceutical Market Insights and Brand Strategist who partners with industry thought leaders, marketing executives, and external agencies to bring compelling and actionable insights to guarantee commercial success and optimal positioning. After spending nearly a decade as a syndicated market research, competitive intelligence and consulting lead at Scott-Levin, Ken moved on to the manufacturer side of the industry where he has led US and Global market research, analytics, and forecasting efforts for Oncology and Rare Disease therapies at Wyeth, GSK, and now Jazz Pharmaceuticals.
Ken’s vast experience has embedded in him a passion for delivering hard-hitting insights, and a bedrock belief that market research is “the analytical conscience” of any organization.
Ken holds a BA in Communications and Journalism from Bloomsburg University, and an MBA in Pharmaceutical and Healthcare Marketing from Saint Joseph’s University in Philadelphia. He is a published novelist who attends local writers’ workshops and groups whenever he has the time. Ken served six years as an Infantryman in the Pennsylvania Army National Guard and lives in Collegeville, PA with his wife and two daughters.
Michael Kostelansky, Daiichi Sankyo, Inc.
Michael Kostelansky, Director, Global Market Research BD, Daiichi Sankyo, Inc.
Michael Kostelansky currently leads a team responsible for executing market assessments on business development and licensing opportunities under consideration by Daiichi Sankyo. The team’s specific responsibilities include conducting all related market research, analytics, CI, forecasting, as well as, valuation support.
Prior to joining in the BD group in 2013, Michael held a role in Daiichi’s New Products Business Analytics Group supporting a number of oncology pipeline products.
Prior to Daiichi Sankyo, Mike consulted for about 5 years with Easton Associates, a boutique strategic consultancy serving life sciences companies.
Mike obtained a Ph.D. in Chemistry at the University of North Carolina at Chapel Hill, and completed a post-doc at the National Institutes of Health (NIH) as PRAT Fellow. He also received an A.B. in Chemistry from Franklin & Marshall College.
John Lauria, LCN Consulting, Inc.
John Lauria, Co-Founder, LCN Consulting, Inc.
John Lauria is the co-founder of LCN Consulting, Inc. He has over 20 years of life science industry experience working with experts in multiple therapeutic areas with the majority of that time spent in business intelligence. He has extensive knowledge of all facets of assessing the external ecosystem from his roles as a collector, manager, analyst, and executive. John has a MA in Psychology and completed doctoral coursework at Pace University.
Michael Luciano, AstraZeneca
Michael Luciano, Sr. Insight Manager, Respiratory Biologics, AstraZeneca
Michael Luciano is a sales, strategy and marketing professional with over twenty years experience in the BioPharma industry. Michael has diverse therapeutic area exposure with an emphasis in oncology, is an award winning sales leader, and is a highly motivated, team player. He is an excellent communicator with strong customer interfacing skills and has an M.B.A in Marketing.
Megan Lund, Insmed Incorporated
Megan Lund, Associate Director, Market Research, Insmed Incorporated
Megan is a passionate insights leader with broad therapeutic knowledge and proven ability to drive brand strategy through the integration of insights from primary and secondary data sources. Megan brings over ten years of combined primary and secondary market research experience across pharmaceutical & consumer industries. She most recently joined Insmed, a biotech company focused on transforming the lives of patients battling serious rare diseases. Megan currently leads the organization’s primary market research efforts and is focused on uncovering key stakeholder insights at a local level.
Scott von Lutcken, Merck
Scott von Lutcken, Director, Global Customer Insights, Merck
Scott von Lutcken leads the Customer Strategy Team for Merck’s Global Market Research Excellence Group. He supports adherence, health literacy and customer engagement. Scott has been an advocate for the customer and patient throughout his career and led numerous projects identifying ways to optimize messaging to customers and patients. Scott joined Merck (Schering-Plough) in 2006, and has worked across several therapeutic areas, supported Sales, and the Chief Medical Office in market research. He received his MBA from Drexel University.
Laura Mace, Lifescience Dynamics
Laura Mace, Ph.D., MBA, Engagement Manager, Lifescience Dynamics
Laura began her career in R&D at GSK in 2005, where she worked to create the manufacturing route for Vilanterol, the ultra-LABA component of Breo / Relvar Ellipta, which launched in 2013. However, after nearly 5 years at the scientific coalface, she decided on a move into the commercial side of pharmaceuticals, completing an MBA and joining Lifescience sales and marketing experts ZS Associates in 2012. At ZS, she tackled questions of sales force optimisation, PRMA via payer research, market research, and Medical Education strategy, at the portfolio level and within oncology, psychiatry and in diabetes. Since 2014, she has been refining her commercial pricing skills at Pearson Ham, a cross-market pricing specialist, and is a recent joiner to Lifescience Dynamics in the Market Access and P&R team.
Laura has a DPhil in synthetic chemistry and an MChem in chemistry from the University of Oxford. Her MBA, for which she was awarded the annual prize for Best Full-Time MBA, was awarded by the Alliance Manchester Business School.
Steve Martino, M Health
Steve Martino, Co-Managing Partner, M Health
Steve is an award-winning advertising writer and creative director with 30 years of experience in helping marketers recognize opportunities, define strategies and build integrated campaigns in several industries. He began his career at consumer ad agencies working on CPG and automotive accounts. Since 2001 he has been working with global biopharma and healthcare clients. Steve combines a deep understanding of strategy with a highly creative vision.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Richard McCloud, Pfizer
Richard McCloud, Director, Pfizer
Rich McCloud is a Director for Business Analytics and Insights, supporting the Pfizer Biosimilars portfolio and Elelyso. Rich joined Pfizer in 1999 in Global Market Analytics where he held roles supporting project teams including Lyrica, Vfend, Celebrex and Bextra. Rich has over 14 years of pharmaceutical market research and consulting experience. His prior experience includes strategy development, HCP positioning and messaging, DTC campaign development, and forecasting.
Rich joined Genentech in 2007, where he gained biologics and respiratory therapy area experience working on Xolair. He embarked as a consultant, and worked primarily with Eli Lilly where he launched the fibromyalgia indication, and developed the very successful DTC campaigns for the chronic pain and depression indications. Rich returned to New York and Pfizer in 2009 to work on Lyrica, and recently joined the Biosimilars team in 2013.
Rich earned a bachelor’s degree in Business Administration from Florida A&M University, and a Master’s degree in market research from University of Georgia. He currently resides in Jersey City, NJ, and is the proud father of his daughter, Lillian.
Tim Mooney, Alnylam Pharmaceuticals
Tim Mooney, Associate Director, Market Insights, Alnylam Pharmaceuticals
Suraj Moorthy, EMD Serono, Inc.
Suraj Moorthy, Senior Director, Global Forecasting, EMD Serono, Inc.
Suraj Moorthy is currently part of the Global Business Intelligence group at Merck Serono/EMD Serono. As GBI’s Oncology Key Business Partner, he coordinates the activities of a global team that supports Merck Serono’s oncology and immune-oncology franchise, covering all in-market and pipeline assets, as well as any external business development opportunities. GBI helps analyze worldwide market dynamics and product performance, monitors the competitive landscape and competitor strategy, generates customer insights through market research, helps design and test global branding campaigns, and is responsible for forecasts and evaluations.
Prior to that, Suraj built the Global Forecasting Center of Excellence at Merck Serono. His team helped forecast and evaluate all in-market, pipeline and external asset opportunities for Merck Serono’s portfolio in oncology, immuno-oncology, neurodegenerative disease, immune/inflammation indications, fertility, and associated medical devices.
Suraj joined EMD Serono from Sanofi Oncology, where he was the Senior Commercial Expert on the Oncology Global Strategy and Portfolio Management group, and worked closely with Global Marketing to generate asset valuations for external opportunities, and inform the deal structure for in-licensing and acquisition of external assets. Before that Suraj established and lead the Business Analytics group for Sanofi Oncology, supporting a legacy portfolio, new pipeline products and business development. During his tenure the team helped drive launch preparation activities for five late phase cancer assets. Prior to joining Sanofi, Suraj held positions in the Global Health Outcomes and Business & Commercial Analysis groups of GlaxoSmithKline Oncology, and at ZS Associates.
Suraj has an MBA from the Wharton School of Business, and received a Ph.D. in Biochemistry as a James B Duke Fellow at Duke University. Suraj lives near Boston, MA, with his wife and young son.
Mike Moran, Eagle Pharmaceuticals, Inc
Mike Moran, Vice President – US Head of Sales, Eagle Pharmaceuticals, Inc
Michael Moran is an industry veteran with more than 20 years of experience in pharmaceutical Sales and Marketing. Prior to joining Eagle Pharmaceuticals as VP US Head of Sales, he spent eight years in various leadership roles at GlaxoSmithKline, including most recently the role of Field Vice President, where he oversaw more than 200 sales representatives and staff.
His additional accomplishments at GlaxoSmithKline include successfully coordinating several product launches across a global footprint, and negotiating the acquisition and co-promotion of additional products in multiple therapeutic areas. He has received numerous awards in recognition of his outstanding leadership and sales achievements.
Anita Natzkova, Teva Pharmaceutical
Anita Natzkova, Ph.D., Director Research Insights and Market Intelligence, Teva Pharmaceutical
• Leads primary and secondary MR for the MS, Cardio-vascular Metabolic, Oncology TAs and Company Branded Generics and delivers Insights for strategic decisions (Reporting, Marketing Plans, AOP or LRP) to internal customers: Marketing, Portfolio, Pricing & Reimbursement departments
• Works with Country stakeholders to produce high business impact insight studies that aim to drive growth
• Determines industry trends (competitors) in Growth Markets and highlights opportunities or threats to TA leads using comprehensive reporting
• Forecasting for pipeline products
Anindita Niyogi, Pfizer
Anindita Niyogi, Director, Market Analytics – Specialty Care, Pfizer
Tom Nolte, Research Partnership
Tom Nolte, Director and Head of Business Analytics, Research Partnership
Tom Nolte is a Director and Head of Business Analytics based in the Philadelphia office. He is a strategist in market research-based global initiatives, corporate direction and portfolio strategy with extensive experience in the life sciences and education. He has an emphasis in innovation and strategic market analytics in areas such as product opportunity, proof of concept, positioning and advanced analytics. Tom has been working in the pharmaceutical and medical device industries for more than 25 years. Tom is also a senior consultant at the University of Pennsylvania in early-stage healthcare commercialization and innovation, and is a frequent lecturer in quantitative research approaches.
Kathleen Pearson, Lilly
Kathleen Pearson, Senior Director Lilly Market Research, Lilly
Kathleen leads the Market Research function for Eli Lilly’s Biomedicines Business Unit where she serves as Senior Director. Kathleen is a market research professional with over twenty years marketing and primary market research experience. Prior to Lilly, she directed an agency team dedicated to global consumer and business-to-business research for large multi-national clients. In the industry, she is best known for her work supporting Oncology business intelligence and for the development of competencies for market research talent. She is recognized for her ability to develop associates’ technical and transferable skills, earning her Lilly’s prestigious “Manager of Choice” award. Kathleen graduated magna cum laude from DePauw University and earned her M.B.A. from the Kelly School of Business at Indiana University. Kathleen previously served on the executive board of the Pharmaceutical Business Intelligence Research Group, holding the office of Vice President, Primary Research.
Married with two children, she enjoys cooking, home improvement, biking, and reading.
Adelene Perkins, Infinity Pharmaceuticals
Adelene Perkins, Chair, President and CEO, Infinity Pharmaceuticals
Adelene Perkins serves as Infinity’s Chief Executive Officer and Infinity’s Chair. She was named CEO and elected to the Board of Directors in 2009. Ms. Perkins joined Infinity in 2002 and served as Infinity’s President, Executive Vice President and Chief Business Officer before being named CEO.
Ms. Perkins joined Infinity from TransForm Pharmaceuticals as an early member of the management team that built the company prior to its acquisition by J&J. From 1992-1999, she was at Genetics Institute, now a unit of Pfizer, where she was vice president of emerging businesses and the cofounder and general manager of the DiscoverEase™ business unit. She also formed and served as chief executive officer of MetaMorphix, a joint venture between Genetics Institute and Johns Hopkins University. From 1985-1992, Ms. Perkins worked at Bain & Company, an international strategy consulting firm, providing advice to clients in the healthcare industry.
Ms. Perkins received her M.B.A. from Harvard Business School and her B.S. in chemical engineering from Villanova University. In addition to chairing the Infinity (NASDAQ: INFI) Board, she is on the Boards of Bruker Corporation (NASDAQ: BRKR), Massachusetts General Hospital, BIO (Biotechnology Industry Organization), the Massachusetts Biotechnology Council, and is the Vice Chairman of the Board of Project Hope. She is a past member of the Boards of Padlock Therapeutics, prior to its acquisition by Bristol-Myers Squibb, and the Massachusetts Life Science Center.
Bill Pilat, Lilly
Bill Pilat, Market Research Director, Lilly
Josh Plumb, Intarcia Therapeutics
Josh Plumb, Senior Director, Payer Marketing, Intarcia Therapeutics
Josh Plumb is currently Senior Director of Payer Marketing at Intarcia Therapeutics, Inc. Josh is responsible for developing and implementing marketing strategies and plans for payers, IDNs, and other organized customers. Previously Josh was Market Access Director at Cubist Pharmaceuticals, leading 15 key account managers that spanned the East Coast. Spanning over a decade, Josh held positions of increasing responsibility at Cubist, from Market Access to Marketing to Analytics to Sales. Josh began his career in politics and also spent time in software. He holds an MBA from New York University’s Stern School and a Bachelor’s degree from Bucknell University.
Rafaat Rahmani, Lifescience Dynamics
Rafaat Rahmani, President, Lifescience Dynamics
Rafaat founded Lifescience Dynamics in the summer of 2004. Thirteen years on, Lifescience Dynamics is privileged to boast an extraordinary worldwide customer base with teams across the globe supporting firms of all sizes, from top 20 pharmaceutical companies through to smaller niche pharma and biotech firms. Previously, Rafaat was Vice President of a London-based consulting practice where he was responsible for numerous international projects focusing on all aspects of the clinical development and commercialisation environments. He has also previously worked for Eli Lilly & Company, Pepsi-Cola and McDonald’s in marketing and management.
Rafaat was born in India, brought up in Oman/UAE, gained a business degree in the USA and an MBA from Manchester Business School in the UK.
Vadim Redchanskiy, Sucampo Pharmaceuticals
Vadim Redchanskiy, Associate Director, Strategic Business Insights, Forecasting & Analytics, Sucampo Pharmaceuticals
Mr. Vadim Redchanskiy joined Sucampo Pharmaceuticals in November of 2016 where he is responsible for Global Strategic Business Insights, Forecasting & Analytics. As a member of Global Strategic Marketing team he also supports management of the company’s business lead product, AMITIZA, and commercial planning for the organization commercial-stage and pipeline-stage opportunities.
Prior to joining Sucampo, Mr. Redchanskiy worked for 13 years at Eli Lilly and Company where he held different commercial and leadership roles to support commercial evaluation and forecasting of business development opportunities as well as supporting the global strategic marketing of early and late-stage pipeline programs for Diabetes, Oncology, Autoimmune and other key therapeutics areas.
Mr. Redchanskiy earned his bachelor and master degrees in Electrical Engineering from Odessa State Maritime Academy, and MBA from Indiana Institute of Technology.
Marjorie Reedy, Merck
Marjorie Reedy, Director, Global Market Research & Analytics, Merck
Marjorie Reedy is a seasoned market research professional with expertise in the pharmaceutical, over the counter and consumer packaged goods sectors. Currently, as Director of Digital & Consumer Innovation at Merck, Marjorie specializes in identifying innovative market research solutions to bring the voice of the patient and the customer to life. Since assuming this role, Marjorie has developed and socialized within Merck a range of “Best Practices” for using Market Research, including non-conscious implicit response technologies, to inform and optimize communications to the healthcare professional and patient communities.
Marjorie is the Merck Ambassador to The Advertising Research Foundation (ARF), and a member of Healthcare Businesswomen’s Association (HBA), Pharmaceutical Marketing Research Group (PMRG), and Pharmaceutical Business Intelligence and Research Group (PBIRG).
Grace Samoil Reynolds, Celgene
Grace Samoil Reynolds, Global Market Insights H/O, Celgene
Grace is Global Market Insights H/O at Celgene. She was previously at Johnson & Johnson where she joined in 1997 in the Market Research Department at Personal Products (consumer). She then progressed through roles in Market Research and Forecasting management in the Pharmaceutical Sector, including responsibility for Women’s Health, Urology and Pain at Ortho McNeil. Most recently, she was responsible for Market Research and Forecasting for the CNS and Pain Franchises in early Pharmaceutical Development. She also has experience in Oncology, Anemia, Metabolics, and Mens Health. Prior to J&J, Grace worked at Schering Plough and Colgate Palmolive, primarily in a Market Research capacity.
Grace earned her MBA at Rutgers University in New Jersey and holds a Bachelors in Chemistry from McGill University, Montreal, Canada. Her passion is driving innovation and future thinking.
Andreia Ribeiro, Lifescience Dynamics
Andreia Ribeiro, Ph.D., Engagement Manager, Lifescience Dynamics
Andreia is an Engagement Manager at Lifescience Dynamics where she leads a variety of Market Access and competitive intelligence projects. Prior to joining the firm, Andreia worked for over 5 years at Decision Resources Group where she was most recently Director of Global Intelligence at the Market Access team. There she managed and/or collaborated in a variety of market research and market access projects and has extensive experience in global market access, HTA, payer systems, and P&R strategy across several therapeutic areas.
Andreia has a Ph.D. in chemical and biochemical engineering from the University of Maryland Baltimore County and a B.S./M.S. degree in chemical engineering from the University of Porto in Portugal. She also holds two professional certifications in biochemical regulatory engineering and biotechnology management.
Jeffrey Riley, Synthetic Biologics
Jeffrey Riley, CEO, Director and President, Synthetic Biologics
Mr. Riley is the CEO, President and a Director of Synthetic Biologics. With more than 20 years of experience in the biotechnology and pharmaceutical industries, he has negotiated numerous worldwide strategic corporate alliances, established joint ventures, and assisted in obtaining venture financings to support product development. Most recently, he served as Managing Director of 526 Ventures. Prior to this, he was a venture partner with QIC Bioventures Fund, held senior positions within the mergers & acquisitions and in-country management groups at SmithKline Beecham and Pfizer, and served as CFO and VP Corporate Development for Nichols Institute Diagnostics, later acquired by Corning and spun out to Quest Diagnostics, Inc. Mr. Riley holds a Bachelor of Science degree from Boise State University, completed coursework at UCSF/Berkeley in drug discovery/development and completed a dual-degree graduate program (MBA/MIM) sponsored by Arizona State University and the Thunderbird School of Global Management.
David Rosen, Purdue Pharmaceuticals
David Rosen, Executive Director, Forecasting, Analytics & Market Research, Purdue Pharmaceuticals
David currently leads the Forecasting, Analytics and Market Research group at Purdue. David began his career at Purdue 13 years ago as a Forecasting Manager but soon worked his way up into significant additional responsibilities. Prior to joining Purdue, he was a consultant at Easton Associates, an international consulting firm specializing in product and business strategy for companies in the life sciences industries. There David led opportunity assessments, due diligence analyses and go to market strategies for numerous novel pharmaceutical therapies, medical devices and diagnostic tests. David began his pharmaceutical career at Bristol Myers Squibb, where he was selected to participate in their management development program.
David holds a Bachelor of Arts in Psychology from Cornell University. In addition, he holds a Masters of Business Administration in Healthcare Finance and Strategy and a Masters of Public Health with honors, both from Yale University.
Igor Rudychev, AstraZeneca
Igor Rudychev, Sr. Business Insights Director, AstraZeneca
Igor has 22 years of the business data analytics & operations experience and for the last 16 years he has been specializing in the Pharmaceutical Sales & Marketing Operations, Data Analytics, Patient-Level Data (APLD), Real World Data, Resource Allocation & Optimization, Brand Analytics, and Forecasting. In the previous roles Igor was leading Global Resource Allocation Team & Oncology Commercial Assessment with Pfizer.
Prior to joining AstraZeneca, Igor was a Vice President of Operations with Bayser, Management Consulting firm in Chicago, where he provided strategic and analytical insights to the top 20 global pharmaceutical companies.
Igor talks at major pharmaceutical & forecasting conferences also published extensively in the trade & peer review journals (including ASCO, PMSA, World Lung, WorldCongress, CBI, AMCP, MMM, PDT, , etc.)
Igor has an MBA from the University of Chicago Booth School of Business and PhD in analytical discipline from Texas A&M University.
Paul Saatsoglou, Ipsen
Paul Saatsoglou, VP Strategy/Operations-North America, Global Program Director-Worldwide, Ipsen
Paul jointed Ipsen in May 2014 after working at Onyx Pharmaceuticals furthering his career in forecasting, primary market research and analytics during his 35+ years of pharmaceutical experience.
His expertise is forecasting new product launches, through the formation of multidisciplinary launch teams, primary data collection and generation of metrics to track performance while using competitive intelligence to assess the competitive impact on launches. While driving Ipsen’s forecasting, Paul is also leading critical operational improvement, strategic projects and process improvements
Paul’s primary focus has been Oncology, Neurology and Rare diseases. He recently assisted in the launches of Samtuline Depot, Onivyde and Dysport.
Paul’s pharmaceutical experience includes roles at Eisai, BMS, J&J and Pfizer.
Steve Schafer, Brädo Creative Insight
Steve Schafer, Senior Director, Brädo Creative Insight
Joel Schindler, MarketVision Research
Joel Schindler, Ph.D., Senior Vice President, Practice Lead – Oncology and Rare Disease, MarketVision Research
Dr. Joel M. Schindler brings a unique blend of experience and insight to healthcare market research. Dr. Schindler received a Ph.D. in molecular biology, held faculty positions at several medical schools and served as a program director at the National Institutes of Health (NIH). Following his NIH tenure, Joel began his career in marketing and marketing research including the last 18 years specifically in the pharmaceutical/biotechnology marketing research arena. Dr. Schindler has published extensively in both the biomedical and marketing arenas.
Jigisha Shelat, Bristol-Myers Squibb
Jigisha Shelat, Director, Customer Insights, Bristol-Myers Squibb
Ms. Jigisha Shelat is currently the market research lead for OPDIVO® at Bristol-Myers Squibb, responsible for the lung cancer, head and neck, and biomarker indications. Jigisha has over a decade of Global and US experience leading marketing research in the pharmaceutical industry through all phases of product development.
Jigisha has successfully launched three extremely critical specialty brands for Bristol-Myers Squibb, OPDIVO® (Nivolumab), YERVOY® (Ipilumimab) and ORENCIA® (Abatacept). In addition, she has led market research, identifying competitive market threats on Eliquis and recommended solutions that turned around brand performance. Jigisha was selected in 2015 to serve on the prestige market research executive board of the Rutgers Business School.
Prior to joining Bristol-Myers Squibb, Jigisha conducted market research within the consumer-packaged goods industry for Kraft Foods Inc. specialized candy business (Altoids® and Life Savers®). Jigisha led the market research plan to successfully position and advertise Creme Savers®, a lead product for the franchise.
Jigisha holds an MBA from Cornell University, from the Johnson School of Business and a Bachelor’s of Science from Cornell University in Management Economics. She was Captain of the Division 1, Varsity tennis team leading the team to the first ever NCAA tournament. She currently lives near Princeton and enjoys being active outdoors, reading and spending time with family and friends.
Donna Simpson, Segmedica
Donna Simpson, Principal, Segmedica
Prior to joining Segmedica, Donna had worked in the biologics area for over 25 years, spending much of that time in marketing, sales and market research. In the span of her career, she has managed a large sales force, contributed extensively to sales and marketing efforts for a major division of a biotech supply firm while continuing to advance in the areas of marketing research using her skills to devise strategies for improved ROI’s in every segment she was responsible for. One of the key areas she has spent time on in her former career was marketing strategy, assisting in the emergence of a new market for many products and services to the pharmaceutical and biotech industry. As Principal and CEO, Donna oversees the Operations of our key project managers and directors as well as the Operations personnel to ensure that our standards remain the highest in the industry.
Peter Simpson, Segmedica
Peter Simpson, Principal, Segmedica
Thirty five years of business experience have taken Peter all over the globe. He has lived and worked in the US, UK and Belgium. He has operated in most of the world’s major markets, including Japan and all of Europe. Most of his career has been spent in the Specialty Chemical, Pharmaceutical, Medical Device and Biotechnology areas. His experiences have included the General Management of major businesses, CFO of several companies, Strategic Planning Executive for businesses up to $2.5BN of revenue, as well as acquisitions and divestments, all within the precursor units of AstraZeneca. He is a member of the Royal Institute of Chartered Management Accountants.
He has been Director of Marketing at Life Technologies Inc., a global supplier to the Biotechnology and Biopharmaceutical industry and Vice President of Consulting and Market Research at Lowe Healthcare, one of the world’s largest medical advertising agencies.
His client experience includes AstraZeneca, Schering Plough, Johnson and Johnson, TAP Pharmaceuticals, Boston Scientific, C R Bard, Pfizer, Merck and many more leading companies. He has also worked with HMO’s, Hospitals and Physicians’ Practices.
Peter’s skills include strategic planning processes, branding issues, healthcare marketing and innovative market research. In over a decade of consulting with the healthcare industry he has conducted numerous research projects of all types and is an experienced interviewer and facilitator. He has been researching and developing psychology based methodologies for medical market research for seven years and has developed a number of novel techniques and processes.
Geoff Stamper, Bristol-Myers Squibb
Geoff Stamper, Director, Integration and Demand Planning, Bristol-Myers Squibb
Geoff Stamper has over 17 years of experience in the pharmaceutical industry, having served in a number of functional areas including development, discovery research, portfolio management, and commercial. He has spent the last 6 years in forecasting and strategic planning where he has supported both the US market and WW brand teams across a number of therapeutic areas. Currently he is the Director of Integration and Demand Planning, where he leads the team responsible for WW operational and long-term gross demand and the long-term revenue outlook.
John Surie, M Health
John Surie, Customer Insight Director, M Health
John is a strategic brand planner and customer insight specialist with 20 years experience in the development of insight-led international brand positioning and communications concepts. He brings a deeper, more insightful understanding of patient, healthcare provider and payer mind states and attitudes, rooted in an in-depth knowledge of the key global healthcare markets.
In 2009 he co-founded M Health, an insight-based brand consultancy focused exclusively on healthcare.
Kathryn Ticknor, Inspire
Kathryn Ticknor, Sr. Research Manager, Inspire
Kathryn is a health communications and medical market researcher with expertise in linguistic insights, ethnography, human-centered design and unstructured data analysis. Motivated by her own family’s experience with chronic illness, she has focused her work on in-depth, disease-state specific research across a variety of conditions including Type II Diabetes, Multiple Sclerosis, Parkinson’s Disease, rare disease, and Oncology. Prior to Inspire, Kathryn supported partners across the healthcare space, including top 50 pharmaceutical companies, private and federal health systems, as well as digital technology partners focusing on patient experience across the continuum of care.
Mladen Tomich, DRG
Mladen Tomich, Ph.D., Executive Director, DRG
Mladen Tomich, Ph.D., is an Executive Director at Decision Resources Group (DRG) where he leads the Infectious, Niche, and Rare Diseases department. In his role Dr. Tomich manages DRG’s syndicated market research portfolio across anti-infectives and orphan drug markets, providing comprehensive data, analyses and business insights to the biopharmaceutical industry. Dr. Tomich also manages DRG’s syndicated Real World Data portfolio, spanning numerous therapeutic areas. He holds a Ph.D. in Microbiology from The University of Minnesota and completed postdoctoral studies at Columbia University. Previously, Dr. Tomich was the Director of Hospital Market Analytics at DRG’s Arlington Medical Resources. Prior to joining DRG, Dr. Tomich worked in pharmaceutical research and development at Merck and Medimmune/AstraZeneca, focusing on the discovery of new antibiotics and monoclonal antibodies for the treatment of serious bacterial infections.
Alexine Tranquada, Merck
Alexine Tranquada, Team Leader, Merck
Alexine Tranquada is a recognized pharmaceutical top talent with almost 20 years of experience analyzing and developing marketing strategies with entrepreneurial spirit and ownership. She is committed to optimizing performance with agility in dynamic and ambiguous environment. She has expertise in all stages of the product life cycle, multiple therapeutic areas, US and global. She has a proven history of utilizing best practices for outstanding results. She is currently leading the Global and Customer Brand Insight (GCBI) team for Merck Biosimilars Business. This business is in launch mode for the first biosimilars developed by Merck and Samsung Bioepis. Previously, Alexine was responsible for the market research and analytics for Diversified Brands and Immunology franchises. She built the capabilities of the original Diversified Brands market research function, bringing consistent high performance, deep analytical insights, high energy, efficiency and leadership skills, to develop foundational institutional building blocks for loss of exclusivity and post-patent success. Alexine held various roles of increasing responsibility including with the cardiovascular franchise (both marketing and market research), regional market research training, and Market Research Excellence.
Alexine has been with Schering-Plough and Merck for the past nine years, and was previously an Associate Vice-President at GfK. She held roles of increasing responsibility in both custom and syndicated market research, including leading the syndicated research in cardiovascular, metabolics and GI. Prior to entry in the pharmaceutical industry, Alexine worked in basic animal-model laboratory research at the University of Pittsburgh.
Alexine has a Bachelor of Science from McGill University (in Microbiology and Immunology with a minor in Management) and an MBA from the University of Pittsburgh with concentrations in Marketing and Strategy. Outside of work, Alexine is an avid runner and mother of three children, Ella (age 13), Calvin (age 10) and Miles (age 6).
Daryl Travis, Brandtrust
Daryl Travis, CEO, Brandtrust
A trusted advisor to many of the largest and best brands in the world, Daryl Travis is a rare breed of author, thought leader and highly regarded consultant. His first book Emotional Branding pioneered the idea that brands are largely about feelings not facts.
As Founder and CEO of Brandtrust, his teams apply social and behavioral science to reveal deeper human truths that solve complex brand, innovation and customer experience challenges for many global brands.
He could be described as a professor, detective, journalist, psychologist and writer all rolled into one. A colorful and engaging storyteller, Daryl speaks frequently on the power of human truths to change everything including how you think about your customers and your business. He explains how research can lead us astray or help us to gain a competitive edge. “Most research discloses what happens,” he says. “However, it often fails to reveal why it happens or the underlying emotional drivers that are critical in creating an effective strategy.” Daryl’s guiding mantra is The NINA Principle®: No Insight—No Advantage®.
Passionate about learning and understanding more about how people think, Daryl is always reading a new book—more than one hundred each year. His voracious reading helps leverage recent breakthroughs in the social sciences to improve the consumer research process, tapping into the deeper underlying emotions and nonconscious motivations critical to revealing insights.
Daryl and his wife Donnita extend his continuous learning passion as active members of Chicago’s philanthropic community, volunteering time and resources to support education and literacy programs for underprivileged children throughout the city.
Cindy Tullis, Directions Research
Cindy Tullis, Sr. Vice President, Directions Research
A former J&J veteran, Cindy has a unique understanding of how to utilize insights to drive business growth. She is the leader of the Healthcare Division at Directions and has a passion for innovation and product development. Over her career she has led multiple teams through the innovation process, resulting in a number of successful introductions in-market.
Heather Turkoz, UCB
Heather Turkoz, Associate Director, Market Research, UCB
Jeet Uppal, Bristol-Myers Squibb
Jeet Uppal, Worldwide Lead – Global Market Research Capabilities, Bristol-Myers Squibb
Jeet is currently the Worldwide Lead, Market Research Capabilities & Enablement at Bristol-Myers Squibb. He leads a team of Researchers and his group responsibilities include managing tracking studies across all therapeutic areas and regions, social listening, MR agency management, knowledge management, training and best practice. Earlier he also established and led the oncology patient chart audit at BMS.
Prior to BMS, Jeet was the Global Group Director for Global Market Research at Zoetis. Jeet led a global team of market researchers and was responsible for Market Research across all species, regions and new products. Jeet joined Pfizer in 2003 as Director, Global Market Research. Pfizer spun off to Zoetis in 2012.
Jeet worked in Pfizer Human Pharmaceutical Opthalmology and Oncology disease areas. He led Pfizer Opthalmology’s market research US and worldwide teams for Glaucoma (Xalatan & Xalacom), Macular degeneration (Macugen) and New Products (Dry eye, DME, strategic evaluation of new disease areas and licensing/development opportunities). Prior to moving to Animal Health, Jeet worked in Pfizer’s Oncology TA and led market research for Oncology New Products and Business Development.
Prior to joining Pfizer, Jeet worked for 10 years in marketing and market research at premier companies including Procter & Gamble, PepsiCo International and Reliant Energy. Jeet started his market research career at Procter & Gamble, where he led core projects across P&G’s Paper, Home-Care and New Ventures business units. Jeet has led market research efforts on multiple billion dollar plus brands like Bounty, Luvs, Pampers, Cascade and Dawn, leading both established business and new ventures. Jeet led PepsiCo’s international market research for the core Pepsi brands. At Reliant Energy, Jeet led direct marketing and market research for the deregulating utility market.
Jeet received his MBA from University of Chicago with specialization in strategy and finance. He holds a Masters in Environmental Engineering from Pennsylvania State University.
Tim Urmston, SEEK Company
Tim Urmston, Founder and CEO, SEEK Company
I’m Founder and CEO. Yep, that means I started it. I guess that means I run it. But the reality is that this thing called SEEK is a beautifully orchestrated ecosystem of the curious collective. I’m the guy that empowers and encourages the team, sets the vision for the entire company and strives to release the full potential in every person that works here. Let’s be honest…it’s a great gig!
I’m home grown in Cincinnati, OH. I have an MBA from Xavier University. I married out of my league and often find myself in awe and wonder how that happened. I have 4 great kids with great hearts. I started SEEK with a very strong aversion to apathy, complacency or status quo. After spending 7 years with Procter & Gamble and a profound life pivot, I set off on a journey to create a company where people couldn’t wait to get to work. In 2000, SEEK was born. Since then, I’ve had the pleasure of working with the best and the brightest people in the world. They are insatiably curious, deeply intuitive, and profoundly humble. In fact, there are times I can’t believe I get to work here. Our goal now is to humanize innovation for the world…every person…every project…every chance we get!
Kanchan Vaidya, Bayer HealthCare
Kanchan Vaidya, Deputy Director, Global Market Research, Oncology, Bayer HealthCare
Kanchan Vaidya has 15 years of leadership and functional experience in forecasting, market research and competitive intelligence across Pharmaceutical and Consumer Packaged Goods with intensive knowledge of best practices. Kanchan has demonstrated passion for facilitating dependable, innovative and data-driven strategic decision making.
Strategic leader delivering crisp insights to build business plans, forecasts, brand strategies and new product launch plans in Oncology.
Key accomplishments include:
Frank Wang, Novartis Oncology
Frank Wang, Lung Cancer and Melanoma Lead, Global Business Analysis, Novartis Oncology
Frank Wang has 15+ years’ experience in pharmaceutical industry mostly focusing on oncology area, with evolving responsibilities in global market research, market analytics, and forecasting. He has also been in the roles as regional brand lead in emerging growth market with Novartis Oncology. Frank also worked at EMD Serono, Aventis, HMR and Merck.
Colleen Welsh-Allen, Kantar Health
Colleen Welsh-Allen RN, Vice President, Qualitative Research, Kantar Health
Colleen has over 25 years of experience in the pharmaceutical and healthcare industries. A registered nurse, Colleen’s clinical experience includes Hemodialysis, Coronary Care, Infectious disease, and Critical care medicine (ICU and ER). More than fifteen years ago, Colleen decided to translate her experience as a nurse into a career in medical marketing research.
Colleen’s qualitative research has encompassed many treatment areas and research techniques. She has interviewed many segments in these therapeutic areas such as: KOLs, Physicians, NPs, PAs nurses, patients, and payers.
She is a member of the QRCA (Qualitative Research Consultants Association) and a Co-Director of the Pharmaceutical/Healthcare Committee.
As the Vice President of Qualitative Research Ms. Welsh-Allen oversees all of the qualitative the moderators and is responsible for quality control of all projects as well as moving forward innovation in qualitative research.
Mark Wiley, Aetna
Mark Wiley, Team Leader, Market Intelligence, Consumer Insights, Aetna
Mark began his career in healthcare in 2001 supporting Merck & Co. by developing key relationships with provider constituents at Baylor, Memorial Hermann and Kelsey Seybold hospital systems in Texas. His success continued as both an analyst and later as a professional market researcher informing strategy for Merck’s consumer leadership. Most recently, Mark successfully informed business development and launched multiple brands for Auxilium Pharmaceuticals (Endo). Mark currently leads the market intelligence function at AETNA and continues shaping Healthagen tactics and strategy through provider insights.
Scott Wright, Directions Research
Scott Wright, Vice President, Directions Research
Scott has a long history in pharm research. He helped lead BASES and Nielsen’s expansion into Pharmaceuticals and Medical devices in the early 2000’s. At Directions, he’s remained focused on healthcare, often mining different verticals like CPG and Finance for innovative solutions that increase insight and drive proactive decision making.